A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT06363825 · RECRUITING
Trial details
- NCT number
- NCT06363825
- Sponsor
- Fujian Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-12
- Primary completion
- 2026-04-11
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.